ASPHF
Price
$5.83
Change
+$0.40 (+7.38%)
Updated
Jan 22 closing price
Capitalization
3.91B
PYPD
Price
$3.23
Change
+$0.01 (+0.31%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
51.19M
2 days until earnings call
Interact to see
Advertisement

ASPHF vs PYPD

Header iconASPHF vs PYPD Comparison
Open Charts ASPHF vs PYPDBanner chart's image
ASCENTAGE PHARMA GROUP
Price$5.83
Change+$0.40 (+7.38%)
Volume$400
Capitalization3.91B
PolyPid
Price$3.23
Change+$0.01 (+0.31%)
Volume$449
Capitalization51.19M
ASPHF vs PYPD Comparison Chart in %
Loading...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASPHF vs. PYPD commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Hold and PYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (ASPHF: $5.82 vs. PYPD: $3.22)
Brand notoriety: ASPHF and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 100% vs. PYPD: 12%
Market capitalization -- ASPHF: $3.91B vs. PYPD: $51.19M
ASPHF [@Biotechnology] is valued at $3.91B. PYPD’s [@Biotechnology] market capitalization is $51.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, ASPHF is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYPD’s TA Score shows that 3 TA indicator(s) are bullish.

  • PYPD’s TA Score: 3 bullish, 6 bearish.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while PYPD (@Biotechnology) price change was -5.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

PYPD is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASPHF($3.91B) has a higher market cap than PYPD($51.2M). ASPHF YTD gains are higher at: 116.543 vs. PYPD (5.921).
ASPHFPYPDASPHF / PYPD
Capitalization3.91B51.2M7,639%
EBITDAN/A-29.31M-
Gain YTD116.5435.9211,968%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A8.04M-
Total DebtN/A8.83M-
TECHNICAL ANALYSIS
Technical Analysis
ASPHFPYPD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
9%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
6%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TTEQ30.410.17
+0.56%
T. Rowe Price Technology ETF
ASEA17.150.08
+0.45%
Global X FTSE Southeast Asia ETF
FPXE31.670.04
+0.13%
First Trust IPOX Europe Equity Opps ETF
YMAX13.16N/A
N/A
YieldMax Universe Fund Of Option Inc ETF
GLO5.48N/A
N/A
Clough Global Opportunities Fund

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with NERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then NERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
NERV - ASPHF
44%
Loosely correlated
-1.98%
GPCR - ASPHF
31%
Poorly correlated
+0.68%
NURPF - ASPHF
30%
Poorly correlated
N/A
PYPD - ASPHF
24%
Poorly correlated
+0.31%
GOSS - ASPHF
24%
Poorly correlated
+1.15%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.31%
ELEV - PYPD
30%
Poorly correlated
N/A
SER - PYPD
30%
Poorly correlated
+1.10%
MESO - PYPD
29%
Poorly correlated
-1.70%
PRTA - PYPD
24%
Poorly correlated
-0.39%
ASPHF - PYPD
24%
Poorly correlated
N/A
More